This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by an
educational grant from
Merck Sharp & Dohme Corp.
The epidemiology and incidence of hospital- and community-acquired
Clostridium difficile infection (CDI) has changed over the past
decade resulting in increased cases of initial and recurrent
infection. Up to 25% of patients with an initial episode of CDI
experience disease recurrence. Recurrent CDI is particularly
challenging to manage.
This webcast series will provide
education on reducing the risk of recurrence, patient-specific risk
factors for recurrent CDI, recommended and emerging treatments for
recurrent CDI, and managed care considerations around the prevention
and management of rCDI.
Upon completion of this
activity, participants will be able to:
Examine the clinical burden of C.
difficile infection, including recurrent infections
Assess tools to identify patients
who may be at increased risk for recurrent C. difficile
Outline evidence-based approaches
for the management of first and second recurrences of C.
difficile infection in diverse patient populations
Describe the role of available
antimicrobial agents and biologics for treatment and prevention
of recurrent C. difficile infection
Apply recent evidence-based and
expert consensus strategies for closing critical gaps in C.
difficile infection care transitions and coordination
Examine the recently updated IDSA
and ACG clinical guidelines for the first-line management of CDI
and guideline updates for prevention of CDI recurrence
||A. Krishna Rao, MD, MS
Division of Infectious Diseases
Department of Internal Medicine
University of Michigan Medical School
|Dr. Rao has
received research/grant support from Merck. He has
served as a consultant for Bio-K+ International, Roche
Molecular Systems, and Seres Therapeutics.
MD has no financial relationships with ineligible
companies to disclose.
Jeremy Williams has no financial relationships with
ineligible companies to disclose.
Jacqueline Cole, RN, MS, CMCN has no financial
relationships with ineligible companies to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue